[144] Hims & Hers Health, Inc. SEC Filing

Rhea-AI Filing Summary

HIMS insider Oluyemi Okupe has filed a Rule 144 notice to sell up to 32,160 shares of common stock through Goldman Sachs & Co. LLC. The planned sale has an aggregate market value of $1,127,208, with the shares listed on the NYSE and 219,270,891 shares of this class outstanding. The shares come from equity compensation, including restricted stock units and stock options acquired between February 2022 and December 2025, with some tied to cashless, same-day option exercises.

Over the prior three months, the same seller completed several sales of HIMS common stock, ranging from 11,592 to 85,000 shares per transaction, for gross proceeds between roughly $669,232 and $5,116,923.50. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	32160	1127208	219270891	12/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/15/2025	Acquired as compensation -- Restricted Stock Units	Issuer			11546	12/15/2025	Compensation
Common	12/15/2025	Acquired as compensation -- Restricted Stock Units	Issuer			4618	12/15/2025	Compensation
Common	12/15/2025	Acquired as compensation -- Restricted Stock Units	Issuer			6926	12/15/2025	Compensation
Common	02/24/2022	Acquired as compensation -- Stock Options	Issuer			2178	02/24/2022	Compensation -- Cashless exercise / same-day sale
Common	03/01/2023	Acquired as compensation -- Stock Options	Issuer			3808	03/01/2023	Compensation -- Cashless exercise / same-day sale
Common	12/15/2024	Acquired as compensation -- Restricted Stock Units	Issuer			3084	12/15/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	09/22/2025	23584	1361766.1
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	09/29/2025	85000	5116923.5
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	10/03/2025	11595	669232.09
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	10/17/2025	11592	662221.98
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	11/17/2025	23187	853490.28

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)